This compound is primarily used as an intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring a trifluoromethyl group, is particularly valuable in drug development due to the group's ability to enhance the metabolic stability and bioavailability of potential drug candidates. It is often incorporated into molecules targeting neurological disorders, cancer, and infectious diseases, where the trifluoromethyl group can improve binding affinity to biological targets. Additionally, it serves as a building block in organic chemistry for the creation of complex molecules with potential therapeutic applications.